NDAQ compared with AZN: revenue, margins and what each company keeps, and the suppliers and customers both name

NDAQNasdaq, Inc.

Mkt capRevenueRevenue

AZNAstrazeneca PLC

Mkt capRevenueRevenue

Compare

NDAQNasdaq, Inc.

AZNAstrazeneca PLC

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

NDAQ

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.2%▲+7.47%×2.34

Q2 FY26±3.3%▼−0.53%×0.15

Q1 FY26±3.1%▲+0.78%×0.26

Jan 29 '26±4.6%▼−0.63%×0.13

AZN

No earnings history for AZN.

= impliedNDAQ realized, solidAZN realized, hatchedOne scale, both sides: full bar = 8%× = |realized| ÷ impliedSource: market data

NDAQNasdaq, Inc.

106.25▲+0.61%· post 106.20

Mkt cap$59.0BRevenue$2.4BQ3 FY26Revenue$8.3BFY25

AZNAstrazeneca PLC

186.63▲+7.01%· post 186.35

ClosedOct 30 '26

Mkt cap$289.5BRevenue—Revenue—

Compare

ClosedOct 30 '26

NDAQNasdaq, Inc.

AZNAstrazeneca PLC

106.25▲+0.61%post 106.20

Price

186.63▲+7.01%post 186.35

$59.0B

Mkt cap

$289.5B

Q3 FY26$2.4B

Revenue

—

FY25$8.3B

Revenue

—

NDAQ106.25▲+0.61%vsAZN186.63▲+7.01%ClosedOct 30 '26